Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Check-Cap Ltd Ord (CHEK)

Check-Cap Ltd Ord (CHEK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 63,800
  • Shares Outstanding, K 46,232
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,840 K
  • 60-Month Beta -0.79
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.30
Trade CHEK with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.06
  • Number of Estimates 2
  • High Estimate -0.06
  • Low Estimate -0.07
  • Prior Year -0.46
  • Growth Rate Est. (year over year) +86.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0000 +25.00%
on 03/05/21
2.3900 -47.70%
on 02/17/21
-0.3700 (-22.84%)
since 02/05/21
3-Month
0.3050 +309.84%
on 12/21/20
2.9300 -57.34%
on 01/05/21
+0.8791 (+237.02%)
since 12/04/20
52-Week
0.2430 +414.40%
on 11/04/20
2.9300 -57.34%
on 01/05/21
-0.2700 (-17.76%)
since 03/05/20

Most Recent Stories

More News
Check-Cap Issues Letter to Shareholders

ISFIYA, , /PRNewswire/ -- (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan, the first and only patient-friendly...

CHEK : 1.2340 (+7.30%)
CHEKZ : 0.2150 (-10.42%)
Thinking about buying stock in 3D Systems, Nio, Orchard Therapeutics, Check Cap, or Gevo?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DDD, NIO, ORTX, CHEK, and GEVO.

ORTX : 6.73 (-1.90%)
CHEK : 1.2340 (+7.30%)
GEVO : 6.99 (-0.43%)
DDD : 24.69 (-3.67%)
NIO : 37.97 (-3.34%)
Thinking about buying stock in Aileron Therapeutics, Check Cap, Jaguar Health, Clearside Biomedical, or Gritstone Oncology?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ALRN, CHEK, JAGX, CLSD, and GRTS.

ALRN : 1.3650 (-0.36%)
CLSD : 3.12 (-4.00%)
GRTS : 13.50 (-0.66%)
CHEK : 1.2340 (+7.30%)
JAGX : 1.5850 (-1.55%)
Thinking about buying stock in Zomedica, Check Cap, Jaguar Health, Vale SA, or Workhorse Group?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ZOM, CHEK, JAGX, VALE, and WKHS.

ZOM : 1.7700 (-5.35%)
CHEK : 1.2340 (+7.30%)
JAGX : 1.5850 (-1.55%)
WKHS : 13.87 (-4.08%)
VALE : 17.61 (+0.63%)
U.S. Alternative Financial Services Market Analysis 2020 with In-depth Company Profiles of 19 Players including EZCorp, First Cash, QC Holdings, Western Union and More

, /PRNewswire/ -- The report has been added to offering.

CHEK : 1.2340 (+7.30%)
EZPW : 5.14 (+1.78%)
QCCO : 0.4000 (+0.33%)
WU : 24.10 (+2.68%)
CheckCap Ltd. (CHEK) Upgraded to Buy: Here's What You Should Know

CheckCap Ltd. (CHEK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CHEK : 1.2340 (+7.30%)
Check-Cap Reports Second Quarter 2020 Financial Results and Corporate Highlights

ISFIYA, , /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and...

CHEK : 1.2340 (+7.30%)
CHEKZ : 0.2150 (-10.42%)
CheckCap Ltd. (CHEK) Moves to Buy: Rationale Behind the Upgrade

CheckCap Ltd. (CHEK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CHEK : 1.2340 (+7.30%)
Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification

ISFIYA, , /PRNewswire/ -- . (the "Company" or "Check-Cap") (NASDAQ: CHEK), a clinical-stage medical diagnostics company advancing the development of C-Scan, the first and only preparation-free ingestible...

CHEK : 1.2340 (+7.30%)
Check-Cap Reports First Quarter 2020 Financial Results and Provides Corporate Update

ISFIYA, , /PRNewswire/ -- (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly...

CHEK : 1.2340 (+7.30%)
CHEKZ : 0.2150 (-10.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of colorectal cancer. Check Cap Ltd. is based in Mount Carmel, Israel.

See More

Key Turning Points

3rd Resistance Point 1.6167
2nd Resistance Point 1.4833
1st Resistance Point 1.3167
Last Price 1.2340
1st Support Level 1.0167
2nd Support Level 0.8833
3rd Support Level 0.7167

See More

52-Week High 2.9300
Fibonacci 61.8% 1.9036
Fibonacci 50% 1.5865
Fibonacci 38.2% 1.2694
Last Price 1.2340
52-Week Low 0.2430

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar